Affordable Proton LIGHT aims to deliver cost-effective proton radiotherapy, highlighting a potential selling point for hospitals seeking advanced cancer treatment with lower total cost of ownership.

City-Scale Access The ability to treat patients in major city centers suggests a value proposition around reduced patient travel and streamlined installation in urban healthcare networks.

CERN Technology Leveraging research and credibility from CERN-backed technology can be used to bolster partnerships with research institutions, medical centers, and funding bodies seeking cutting-edge, validated solutions.

Strategic Financing Notable funding activity including convertible loans and capital raises indicates ongoing investor interest; identify co-investment, grant, or debt-syndication opportunities to accelerate product development and deployment.

Market Readiness Low revenue yet substantial funding implies near-term commercialization; target early adopters, radiotherapy centers, and oncology networks that are evaluating next-generation proton beam options for expansion or replacement.